New York State Common Retirement Fund Has $3.54 Million Position in OrthoPediatrics Corp. $KIDS

New York State Common Retirement Fund lessened its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS) by 57.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 191,066 shares of the company’s stock after selling 254,500 shares during the period. New York State Common Retirement Fund owned approximately 0.76% of OrthoPediatrics worth $3,540,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Grandeur Peak Global Advisors LLC acquired a new stake in OrthoPediatrics in the 2nd quarter valued at $452,000. Conestoga Capital Advisors LLC lifted its holdings in shares of OrthoPediatrics by 23.8% during the second quarter. Conestoga Capital Advisors LLC now owns 66,588 shares of the company’s stock valued at $1,430,000 after acquiring an additional 12,795 shares during the period. Mutual of America Capital Management LLC boosted its stake in shares of OrthoPediatrics by 9.3% in the 2nd quarter. Mutual of America Capital Management LLC now owns 185,033 shares of the company’s stock valued at $3,975,000 after purchasing an additional 15,725 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of OrthoPediatrics during the 2nd quarter worth about $220,000. Finally, R Squared Ltd bought a new position in OrthoPediatrics during the 2nd quarter valued at about $272,000. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Stock Performance

OrthoPediatrics stock opened at $16.65 on Friday. The company has a current ratio of 7.40, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 1 year low of $15.28 and a 1 year high of $26.40. The company has a market cap of $417.58 million, a PE ratio of -8.54 and a beta of 1.12. The company’s 50-day moving average is $17.91 and its two-hundred day moving average is $18.53.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Canaccord Genuity Group assumed coverage on OrthoPediatrics in a research report on Wednesday, December 10th. They set a “buy” rating and a $24.00 price target on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. TD Cowen upgraded shares of OrthoPediatrics to a “strong-buy” rating in a research report on Tuesday, January 27th. BTIG Research restated a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, October 29th. Finally, Needham & Company LLC dropped their target price on shares of OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating for the company in a research note on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $23.89.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.